Sorilux

INDICATIONS

SORILUX (calcipotriene foam) Foam is indicated for the topical treatment of plaque psoriasis in patients aged 18 years and older.

DOSAGE AND ADMINISTRATION

For topical use only. SORILUX (calcipotriene foam) Foam is not for oral, ophthalmic, or intravaginal use.

Apply a thin layer of SORILUX (calcipotriene foam) Foam twice daily to the affected areas and rub in gently and completely.

HOW SUPPLIED

Dosage Forms And Strengths

0.005%, white foam

How Supplied

SORILUX (calcipotriene) Foam, 0.005%, is supplied as follows:

60 g aluminum can NDC 0145-2130-06

Storage and Handling

  • Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F).
  • FLAMMABLE. AVOID FIRE. FLAME. OR SMOKING DURING AND IMMEDIATELY FOLLOWING APPLICATION. Contents under pressure. Do not puncture or incinerate. Do not expose to heat or store at temperatures above 120°F (49°C).
  • Avoid contact with eyes.
  • Keep out of reach of children.

Manufactured for: Stiefel Laboratories, Inc. Research Triangle Park, NC 27709. Manufactured by: DPT Laboratories, Ltd. 307 E. Josephine Street San Antonio, TX 78215. Revised: 2010

Last reviewed on RxList: 11/2/2010
This monograph has been modified to include the generic and brand name in many instances.

A A A

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.

Health Resources
advertisement
advertisement
Use Pill Finder Find it Now See Interactions

Pill Identifier on RxList

  • quick, easy,
    pill identification

Find a Local Pharmacy

  • including 24 hour, pharmacies

Interaction Checker

  • Check potential drug interactions
Search the Medical Dictionary for Health Definitions & Medical Abbreviations